The United States Food and Drug Administration (FDA) approved a nerve disease treatment jointly created by AstraZeneca plc and Ionis Pharmaceutical Inc.
The drug in question, titled 'Wainua,' is the only self-administrable drug capable of treating the hereditary "polyneuropathy of hereditary...
Ionis Pharmaceuticals, Inc. will acquire all of the outstanding shares of its subsidiary, Akcea Therapeutics, Inc., the two companies revealed on Monday.
With this move, Ionis, a California-based pharmaceutical firm specialized in discovering and developing RNA-targeted therapeutics, will attain...
This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.
